TrialGeroScience2026

The proBNPage reduction (PBAR) trial-results of a randomized, double blind, placebo-controlled, pilot study to fine tune an NT-proBNP-based method to assess the effect of anti-aging treatments.

Antonio Muscari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.